GTR Home > Tests > Search results - APP[gene]

Apply filters

Showing tests for all 2016 conditions

Compare labs

Your search term can be found in tests with a total of 2016 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

  • Hide states

GTR test search results for 351[geneid]

C Clinical test, R Research test

Showing 1 to 20 of 21 tests for 2016 conditions in 15 labs

CAlzheimer dementia and dementia panel

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total targets (7)

CTruGenome Predisposition Screen

Lab: Illumina Clinical Services Laboratory Illumina San Diego, California, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (1541)
Total targets (1578)

CAlzheimer's Disease, Familial via the APP Gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CAlzheimer Disease Type 1, Alzheimer Disease, Early-Onset Familial

Lab: ATG-GenMed Berlin, Berlin, Germany
Test targets
Methods
  • C Sequence analysis of the entire coding region

CADmark® Early Onset Alzheimer's Evaluation

Lab: Athena Diagnostics Inc Marlborough, Massachusetts, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region

CADmark® APP DNA Sequencing/Duplication Test

Lab: Athena Diagnostics Inc Marlborough, Massachusetts, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

C, APP. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CAPP. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CAPOE, APP, PSEN1, PSEN2. NextGeneDx.Complete sequencing by NGS

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CParkinson Alzheimer Dementia NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (80)
Total targets (36)

CCEREBRAL AMYLOID ANGIOPATHY, APP-RELATED

Lab: MVZ Dortmund Dr. Eberhard and Partner Dortmund, Nordrhein-Westfalen, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons

CAlzheimer disease type 1 (sequence analysis of APP gene)

Lab: CGC Genetics Porto, Porto, Portugal
Test targets
Methods
  • C Sequence analysis of the entire coding region

CAPP: APP gene sequence analysis (exons 16-17)

Test targets
Methods
  • C Sequence analysis of the entire coding region

CAlzheimer Disease Type 1

Test targets
Methods
  • C Sequence analysis of the entire coding region

C Test for Alzheimer Disease Type 1

Lab: Secugen SL Madrid, Madrid, Spain
Test targets
Methods
  • E Sequence analysis of select exons

CAlzheimer Disease Type 1

Lab: Labor-MVZ Westmecklenburg Laboratory for Molecular Diagnostics Schwerin, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons

CAlzheimer Disease Type 1 (APP)

Lab: MVZ Dortmund Dr. Eberhard and Partner Dortmund, Nordrhein-Westfalen, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons

Showing 1 to 20 of 21 tests for 2016 conditions in 15 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Write to the Help Desk